SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 4,515.12 |
Enterprise Value ($M) | 4,563.45 |
Book Value ($M) | 177.57 |
Book Value / Share | 1.24 |
Price / Book | 25.43 |
NCAV ($M) | 180.21 |
NCAV / Share | 1.26 |
Price / NCAV | 25.05 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.03 |
Return on Assets (ROA) | -0.04 |
Return on Equity (ROE) | -0.09 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.91 |
Current Ratio | 4.59 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 574.07 |
Assets | 586.01 |
Liabilities | 393.86 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | |||
13G/A | Darwin Global Management, Ltd. | 0.00 | -100.00 | |
13G/A | BlackRock, Inc. | 14.20 | ||
13G/A | State Street Corp | 5.45 | -20.75 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
388,560 | 1,372,596 | 28.31 | |
324,414 | 1,232,075 | 26.33 | |
387,370 | 1,629,359 | 23.77 | |
438,244 | 1,800,676 | 24.34 | |
(click for more detail) |
Similar Companies | |
---|---|
TCRT – Alaunos Therapeutics, Inc. | TELO – Telomir Pharmaceuticals, Inc. |
TENX – Tenax Therapeutics, Inc. | THAR – Tharimmune, Inc. |
THTX – Theratechnologies Inc. |